Sherwin-Williams Target price 2025 - Analyst rating & recommendation
Sherwin-Williams Classifications & Recommendation:
Sherwin-Williams Price Target
| Target Price | $392.70 |
| Price | $343.69 |
| Potential | 14.26% |
| Number of Estimates | 24 |
| 24 Analysts have issued a price target Sherwin-Williams 2026 . The average Sherwin-Williams target price is $392.70. This is 14.26% higher than the current stock price. The highest price target is $441.00 28.31% , the lowest is $260.98 24.06% . | |
| A rating was issued by 33 analysts: 19 Analysts recommend Sherwin-Williams to buy, 14 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Sherwin-Williams stock has an average upside potential 2026 of 14.26% . Most analysts recommend the Sherwin-Williams stock at Purchase. |
Sales and Margin forecast 2025, 2026 to 2032
28 Analysts have issued a sales forecast Sherwin-Williams 2025 . The average Sherwin-Williams sales estimate is $23.7b . This is 1.72% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $24.8b 6.40% , the lowest is $22.7b 2.52% .
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $23.1b | 0.20% |
|---|---|---|
| 2025 | $23.7b | 2.50% |
| 2026 | $24.8b | 4.93% |
| 2027 | $26.0b | 4.69% |
| 2028 | $27.1b | 4.31% |
| 2029 | $28.3b | 4.16% |
| 2030 | $29.6b | 4.67% |
| 2031 | $30.7b | 3.95% |
| 2032 | $32.0b | 3.95% |
25 Analysts have issued an Sherwin-Williams EBITDA forecast 2025. The average Sherwin-Williams EBITDA estimate is $4.6b . This is 5.47% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $4.9b 13.48% , the lowest is $4.3b 0.85% .
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $4.1b | 3.32% |
|---|---|---|
| 2025 | $4.6b | 11.78% |
| 2026 | $5.0b | 8.84% |
| 2027 | $5.5b | 9.83% |
| 2028 | $5.5b | 0.93% |
| 2029 | $5.8b | 4.81% |
| 2030 | $6.0b | 3.86% |
| 2031 | $6.1b | 2.20% |
| 2032 | $6.2b | 1.84% |
EBITDA Margin
| 2024 | 17.70% | 3.52% |
|---|---|---|
| 2025 | 19.30% | 9.04% |
| 2026 | 20.02% | 3.73% |
| 2027 | 21.00% | 4.90% |
| 2028 | 20.32% | 3.24% |
| 2029 | 20.45% | 0.64% |
| 2030 | 20.29% | 0.78% |
| 2031 | 19.95% | 1.68% |
| 2032 | 19.54% | 2.06% |
30 Sherwin-Williams Analysts have issued a net profit forecast 2025. The average Sherwin-Williams net profit estimate is $2.8b . This is 10.69% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $3.1b 21.94% , the lowest is $2.7b 5.80% .
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $2.7b | 12.25% |
|---|---|---|
| 2025 | $2.8b | 6.17% |
| 2026 | $3.2b | 11.42% |
| 2027 | $3.6b | 12.99% |
| 2028 | $3.9b | 8.34% |
| 2029 | $4.1b | 6.50% |
| 2030 | $4.4b | 5.72% |
| 2031 | $4.5b | 3.78% |
| 2032 | $4.7b | 3.31% |
Net Margin
| 2024 | 11.61% | 12.02% |
|---|---|---|
| 2025 | 12.02% | 3.54% |
| 2026 | 12.77% | 6.24% |
| 2027 | 13.78% | 7.91% |
| 2028 | 14.31% | 3.85% |
| 2029 | 14.63% | 2.24% |
| 2030 | 14.78% | 1.03% |
| 2031 | 14.76% | 0.14% |
| 2032 | 14.66% | 0.68% |
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032
30 Analysts have issued a Sherwin-Williams forecast for earnings per share. The average Sherwin-Williams EPS is $11.48 . This is 11.24% higher than earnings per share in the financial year 2024. The highest EPS forecast is $12.65 22.58% , the lowest is $10.98 6.40% .
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $10.55 | 14.05% |
|---|---|---|
| 2025 | $11.48 | 8.82% |
| 2026 | $12.79 | 11.41% |
| 2027 | $14.46 | 13.06% |
| 2028 | $15.66 | 8.30% |
| 2029 | $16.68 | 6.51% |
| 2030 | $17.63 | 5.70% |
| 2031 | $18.30 | 3.80% |
| 2032 | $18.91 | 3.33% |
P/E ratio
| Current | 33.30 | 13.63% |
|---|---|---|
| 2025 | 29.93 | 10.13% |
| 2026 | 26.86 | 10.26% |
| 2027 | 23.77 | 11.50% |
| 2028 | 21.94 | 7.70% |
| 2029 | 20.60 | 6.11% |
| 2030 | 19.49 | 5.39% |
| 2031 | 18.78 | 3.64% |
| 2032 | 18.18 | 3.19% |
Based on analysts' sales estimates for 2025, the Sherwin-Williams stock is valued at an EV/Sales of 4.07 and an P/S ratio of 3.60 .
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 4.14 | 11.35% |
|---|---|---|
| 2025 | 4.07 | 1.57% |
| 2026 | 3.88 | 4.70% |
| 2027 | 3.71 | 4.48% |
| 2028 | 3.56 | 4.14% |
| 2029 | 3.41 | 4.00% |
| 2030 | 3.26 | 4.46% |
| 2031 | 3.14 | 3.80% |
| 2032 | 3.02 | 3.80% |
P/S ratio
| Current | 3.66 | 13.71% |
|---|---|---|
| 2025 | 3.60 | 1.69% |
| 2026 | 3.43 | 4.70% |
| 2027 | 3.28 | 4.48% |
| 2028 | 3.14 | 4.13% |
| 2029 | 3.01 | 4.00% |
| 2030 | 2.88 | 4.46% |
| 2031 | 2.77 | 3.80% |
| 2032 | 2.67 | 3.80% |
Sherwin-Williams...
Current Sherwin-Williams Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Citigroup |
Neutral
➜
Neutral
|
Unchanged | Oct 30 2025 |
| JP Morgan |
Overweight
➜
Overweight
|
Unchanged | Oct 29 2025 |
| UBS |
Buy
➜
Buy
|
Unchanged | Oct 29 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 29 2025 |
| RBC Capital |
Outperform
➜
Outperform
|
Unchanged | Oct 29 2025 |
| B of A Securities |
Neutral
➜
Neutral
|
Unchanged | Oct 14 2025 |
| Wells Fargo |
Overweight
➜
Overweight
|
Unchanged | Oct 10 2025 |
| Analyst Rating | Date |
|---|---|
|
Unchanged
Citigroup:
Neutral
➜
Neutral
|
Oct 30 2025 |
|
Unchanged
JP Morgan:
Overweight
➜
Overweight
|
Oct 29 2025 |
|
Unchanged
UBS:
Buy
➜
Buy
|
Oct 29 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 29 2025 |
|
Unchanged
RBC Capital:
Outperform
➜
Outperform
|
Oct 29 2025 |
|
Unchanged
B of A Securities:
Neutral
➜
Neutral
|
Oct 14 2025 |
|
Unchanged
Wells Fargo:
Overweight
➜
Overweight
|
Oct 10 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
